đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This phase II trial tests how well pembrolizumab and tazemetostat work to t...
Status
Active Not Recruiting
Location
Northwestern University
Start Date
2024-09-30
Trial ID
NCT06242834
In previous studies, the investigators found that in patients with Hodgkin'...
Status
Completed
Location
Departmetn of Medicine. Meir Medical Center
Start Date
2009-09
Trial ID
NCT00969462
Treatments Being Tested
This is a prospective trial designed to evaluate the use of Meso Wound Matr...
Status
Completed
Location
Royal Research
Start Date
2019-12-05
Trial ID
NCT04182451
Treatments Being Tested
Hypothesis: 1. In patients with less than 4 high risk factors for reintuba...
Status
Completed
Location
Hospital Virgen de la Salud
Start Date
2021-03-01
Trial ID
NCT04758546
The purpose of this study is to improve the outcome of elderly patients wit...
Status
Completed
Location
Saarland University Hospital
Start Date
2011-11
Trial ID
NCT01478542
Cancer is the commonest cause of death in Singapore, and many cancer deaths...
Status
Completed
Location
National University Hospital
Start Date
2008-03
Trial ID
NCT00980122
To compare the angiographic and clinical outcomes of aggressive versus stan...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07391033
The goal of this study is to help children with autism and a co-occurring i...
Status
Recruiting
Location
Children's Mercy
Start Date
2026-10
Trial ID
NCT07624448
Treatments Being Tested
Von Willebrand disease (VWD) is the most common inherent bleeding disorder ...
Status
Completed
Location
Center for Dentistry and Oral Medicine (Carolinum), Johann Wolfgang Goethe-University
Start Date
2015-07-16
Trial ID
NCT03078595
A multicentre controlled phase II trial to compare the efficacy and safety ...
Status
Terminated
Location
UniversitÀtsklinikum Hamburg-Eppendorf
Start Date
2021-08-27
Trial ID
NCT04971005
Treatments Being Tested